1. Home
  2. OMF vs IOVA Comparison

OMF vs IOVA Comparison

Compare OMF & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMain Holdings Inc.

OMF

OneMain Holdings Inc.

SELL

Current Price

$54.81

Market Cap

6.3B

Sector

Finance

ML Signal

SELL

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$7.54

Market Cap

6.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMF
IOVA
Founded
1920
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
6.7B
IPO Year
2013
2008

Fundamental Metrics

Financial Performance
Metric
OMF
IOVA
Price
$54.81
$7.54
Analyst Decision
Buy
Buy
Analyst Count
15
9
Target Price
★ $66.86
$14.50
AVG Volume (30 Days)
878.2K
★ 13.5M
Earning Date
10-30-2026
11-05-2026
Dividend Yield
★ 7.59%
N/A
EPS Growth
★ 54.72
14.84
EPS
★ 1.93
N/A
Revenue
N/A
N/A
Revenue This Year
$78.09
$58.86
Revenue Next Year
$7.97
$41.86
P/E Ratio
$28.65
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$45.78
$2.08
52 Week High
$71.93
$15.37

Technical Indicators

Market Signals
Indicator
OMF
IOVA
Relative Strength Index (RSI) 40.64 31.97
Support Level $54.23 $3.57
Resistance Level $58.78 $9.36
Average True Range (ATR) 1.51 0.76
MACD -0.17 -0.30
Stochastic Oscillator 3.27 0.60

Price Performance

Historical Comparison
OMF
IOVA

About OMF OneMain Holdings Inc.

OneMain Holdings Inc is a consumer finance company providing loan products to customers through its branch network and the internet. The company provides personal loan products; offers credit cards; offers optional credit insurance and others; offers a customer-focused financial wellness program, and acquisitions and dispositions of assets and businesses. It provides origination, underwriting, and servicing of personal loans to non-prime customers. The company operates in single reportable segment Consumer and Insurance which originates and services personal loans and auto finance loans, offer credit cards, and provide optional credit and non-credit insurance and other optional products through its branch and central operations, as well as digital platform.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: